RecruitingNCT06692049

Gonadal Tissue Cryopreservation for Fertility Preservation in Children with a Disorder of Sex Development


Sponsor

Erin Rowell

Enrollment

250 participants

Start Date

Apr 4, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to offer gonadal tissue freezing and storage to children who are diagnosed with a disorder of sex development (DSD), who are at increased risk of infertility and certain malignancies (cancer). This study involves the storage of gonadal tissue that is being removed for medical reasons (e.g. prevention of cancer development). It includes the processing and freezing of this gonadal tissue, hopefully for potential future use. The tissue will then be stored long-term until the child wishes to try to use the tissue.


Eligibility

Max Age: 30 Years

Inclusion Criteria2

  • Individual \< 30 years of age
  • Children diagnosed with a disorder of sex development who have any risk for malignancy in their gonadal tissue or will have their gonads removed for another clinical indication

Exclusion Criteria5

  • Pregnant children
  • Patients likely to retain inherent fertility and reproductive function
  • Children deemed high risk for perioperative complications
  • Patients 12-18 unable to provide assent (i.e. significant psychiatric problems/cognitive delay)
  • Patients 18 and older unable to provide consent (i.e. significant psychiatric problems/cognitive delay)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREGonadectomy

Gonadal tissue being removed for risk of malignancy may be cryopreserved for fertility preservation


Locations(1)

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06692049


Related Trials